George A Poultsides

Summary

Affiliation: Stanford University
Country: USA

Publications

  1. doi request reprint Pancreatic neuroendocrine tumors: radiographic calcifications correlate with grade and metastasis
    George A Poultsides
    Department of Surgery, Stanford University School of Medicine, Stanford, CA, USA
    Ann Surg Oncol 19:2295-303. 2012
  2. doi request reprint Hybrid resection of duodenal tumors
    George A Poultsides
    Division of Surgical Oncology, Stanford University School of Medicine, Stanford, California 94305 5641, USA
    J Laparoendosc Adv Surg Tech A 21:603-8. 2011
  3. pmc Lymph nodes and survival in pancreatic neuroendocrine tumors
    Geoffrey W Krampitz
    Department of Surgery, Stanford University School of Medicine, Stanford, CA 94305 5655, USA
    Arch Surg 147:820-7. 2012
  4. doi request reprint Seventh edition (2010) of the AJCC/UICC staging system for gastric adenocarcinoma: is there room for improvement?
    Manali I Patel
    Department of Medicine, Division of Oncology, Stanford University Medical Center, Stanford, CA, USA
    Ann Surg Oncol 20:1631-8. 2013
  5. ncbi request reprint Surgical management of neuroendocrine tumors of the gastrointestinal tract
    Lyen C Huang
    Department of Surgery, Stanford University School of Medicine, Stanford, California 94305 5641, USA
    Oncology (Williston Park) 25:794-803. 2011
  6. pmc Duodenal adenocarcinoma: clinicopathologic analysis and implications for treatment
    George A Poultsides
    Department of Surgery, Johns Hopkins Medical Institutions, Baltimore, MD, USA
    Ann Surg Oncol 19:1928-35. 2012
  7. doi request reprint Intensity-modulated radiotherapy for pancreatic adenocarcinoma
    Jonathan A Abelson
    Department of Radiation Oncology, Stanford University, Stanford, CA 94305, USA
    Int J Radiat Oncol Biol Phys 82:e595-601. 2012
  8. pmc Metabolomic-derived novel cyst fluid biomarkers for pancreatic cysts: glucose and kynurenine
    Walter G Park
    Department of Medicine, Stanford University, Stanford, California, USA
    Gastrointest Endosc 78:295-302.e2. 2013
  9. pmc Hospital readmission after a pancreaticoduodenectomy: an emerging quality metric?
    Zachary J Kastenberg
    Department of Surgery, Stanford University Medical Center, Stanford, CA 94305 5641, USA
    HPB (Oxford) 15:142-8. 2013
  10. pmc Failure to comply with NCCN guidelines for the management of pancreatic cancer compromises outcomes
    Brendan C Visser
    Department of Surgery, Stanford University Medical Center, CA 94305 5641, USA
    HPB (Oxford) 14:539-47. 2012

Collaborators

Detail Information

Publications14

  1. doi request reprint Pancreatic neuroendocrine tumors: radiographic calcifications correlate with grade and metastasis
    George A Poultsides
    Department of Surgery, Stanford University School of Medicine, Stanford, CA, USA
    Ann Surg Oncol 19:2295-303. 2012
    ..Specifically, the prevalence and prognostic significance of radiographic calcifications in these tumors remains unclear...
  2. doi request reprint Hybrid resection of duodenal tumors
    George A Poultsides
    Division of Surgical Oncology, Stanford University School of Medicine, Stanford, California 94305 5641, USA
    J Laparoendosc Adv Surg Tech A 21:603-8. 2011
    ....
  3. pmc Lymph nodes and survival in pancreatic neuroendocrine tumors
    Geoffrey W Krampitz
    Department of Surgery, Stanford University School of Medicine, Stanford, CA 94305 5655, USA
    Arch Surg 147:820-7. 2012
    ..Lymph node metastases decrease survival in patients with pancreatic neuroendocrine tumors (pNETs)...
  4. doi request reprint Seventh edition (2010) of the AJCC/UICC staging system for gastric adenocarcinoma: is there room for improvement?
    Manali I Patel
    Department of Medicine, Division of Oncology, Stanford University Medical Center, Stanford, CA, USA
    Ann Surg Oncol 20:1631-8. 2013
    ..We sought to validate the new system on a U.S. population database...
  5. ncbi request reprint Surgical management of neuroendocrine tumors of the gastrointestinal tract
    Lyen C Huang
    Department of Surgery, Stanford University School of Medicine, Stanford, California 94305 5641, USA
    Oncology (Williston Park) 25:794-803. 2011
    ....
  6. pmc Duodenal adenocarcinoma: clinicopathologic analysis and implications for treatment
    George A Poultsides
    Department of Surgery, Johns Hopkins Medical Institutions, Baltimore, MD, USA
    Ann Surg Oncol 19:1928-35. 2012
    ..Duodenal adenocarcinoma is a rare cancer usually studied as a group with periampullary or small bowel adenocarcinoma; therefore, its natural history is poorly understood...
  7. doi request reprint Intensity-modulated radiotherapy for pancreatic adenocarcinoma
    Jonathan A Abelson
    Department of Radiation Oncology, Stanford University, Stanford, CA 94305, USA
    Int J Radiat Oncol Biol Phys 82:e595-601. 2012
    ..To report the outcomes and toxicities in patients treated with intensity-modulated radiotherapy (IMRT) for pancreatic adenocarcinoma...
  8. pmc Metabolomic-derived novel cyst fluid biomarkers for pancreatic cysts: glucose and kynurenine
    Walter G Park
    Department of Medicine, Stanford University, Stanford, California, USA
    Gastrointest Endosc 78:295-302.e2. 2013
    ..Better pancreatic cyst fluid biomarkers are needed...
  9. pmc Hospital readmission after a pancreaticoduodenectomy: an emerging quality metric?
    Zachary J Kastenberg
    Department of Surgery, Stanford University Medical Center, Stanford, CA 94305 5641, USA
    HPB (Oxford) 15:142-8. 2013
    ..The aim of the study was to evaluate the frequency and patterns of rehospitalization after a pancreaticoduodenectomy (PD)...
  10. pmc Failure to comply with NCCN guidelines for the management of pancreatic cancer compromises outcomes
    Brendan C Visser
    Department of Surgery, Stanford University Medical Center, CA 94305 5641, USA
    HPB (Oxford) 14:539-47. 2012
    ..We investigated variation in the management of pancreatic cancer (PC) among large hospitals in California, USA, specifically to evaluate whether compliance with NCCN guidelines correlates with patient outcomes...
  11. pmc Pancreatic endocrine tumors with major vascular abutment, involvement, or encasement and indication for resection
    Jeffrey A Norton
    Department of Surgery, Stanford University Medical Center, Stanford, CA 94305 5641, USA
    Arch Surg 146:724-32. 2011
    ..Surgery for pancreatic endocrine tumors (PETs) with blood vessel involvement is controversial...
  12. pmc Diagnostic accuracy of cyst fluid amphiregulin in pancreatic cysts
    May T Tun
    Department of Medicine, Stanford University, Stanford, CA 94305, USA
    BMC Gastroenterol 12:15. 2012
    ..This study evaluated the diagnostic utility of amphiregulin (AREG) as a pancreatic cyst fluid biomarker to differentiate non-mucinous, benign mucinous, and malignant mucinous cysts...
  13. doi request reprint Pathologic response to preoperative chemotherapy in colorectal liver metastases: fibrosis, not necrosis, predicts outcome
    George A Poultsides
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 19:2797-804. 2012
    ..Histologically, dominant response patterns include fibrosis, necrosis and/or acellular mucin, but some of these changes can appear without previous chemotherapy and their individual correlation with outcome is unknown...
  14. doi request reprint Colorectal cancer diagnostics: biomarkers, cell-free DNA, circulating tumor cells and defining heterogeneous populations by single-cell analysis
    Cindy Kin
    Department of Surgery, Stanford University School of Medicine, Stanford, CA, USA
    Expert Rev Mol Diagn 13:581-99. 2013
    ..The detection and characterization of circulating tumor cells and cell-free DNA in colorectal cancer patients will not only improve the understanding of the development of metastasis, but may also supplant the use of other biomarkers. ..